PRESS RELEASE published on 05/23/2024 at 14:30, 2 years 1 month ago Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product Jaguar Health, Inc. announces commercial launch at ASCO Annual Meeting for Gelclair, FDA-approved oral mucositis product. Focus on cancer supportive care with phase 3 OnTarget trial results impending Jaguar Health Phase 3 Trial Gelclair Oral Mucositis ASCO Annual Meeting
BRIEF published on 05/17/2024 at 22:20, 2 years 1 month ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health Inc Reverse Stock Split Nasdaq Compliance Institutional Investors Stock Adjustment
BRIEF published on 05/17/2024 at 22:20, 2 years 1 month ago Jaguar Health, Inc. annonce un regroupement d'actions Investisseurs Institutionnels Conformité NASDAQ Ajustement Des Stocks Regroupement Inversé Des Actions Jaguar Santé Inc.
PRESS RELEASE published on 05/17/2024 at 22:15, 2 years 1 month ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health announces reverse split approval at Special Meeting of Stockholders to boost Nasdaq compliance. Stock trading on split-adjusted basis from May 23, 2024. Details in SEC filing Stockholders Meeting Jaguar Health Nasdaq Compliance Reverse Split SEC Filing
BRIEF published on 05/14/2024 at 14:05, 2 years 1 month ago Jaguar Health Reports First Quarter 2024 Financial Results Financial Results Crofelemer Jaguar Health Q1 2024 Gelclair
BRIEF published on 05/14/2024 at 14:05, 2 years 1 month ago Jaguar Health publie ses résultats financiers du premier trimestre 2024 Résultats Financiers Crofelemer Santé Jaguar T1 2024 Gelclair
PRESS RELEASE published on 05/14/2024 at 14:00, 2 years 1 month ago Jaguar Health Reports First Quarter 2024 Financial Results Jaguar Health, Inc. reports Q1 2024 financial results, with revenue increasing 20% over Q1 2023. Key updates include OnTarget trial progress and Gelclair® commercial launch plans Financial Results Jaguar Health Q1 2024 OnTarget Trial Gelclair
BRIEF published on 05/13/2024 at 18:40, 2 years 1 month ago Jaguar Health, Inc. Announces Q1 2024 Webcast to Discuss Financials and Corporate Updates Earnings Report Jaguar Health Q1 2024 Financial Webcast Corporate Updates
BRIEF published on 05/13/2024 at 18:40, 2 years 1 month ago Jaguar Health, Inc. annonce une webdiffusion du premier trimestre 2024 pour discuter des données financières et des mises à jour de l'entreprise Rapport Sur Les Revenus Santé Jaguar T1 2024 Webdiffusion Financière Mises À Jour De L'entreprise
PRESS RELEASE published on 05/13/2024 at 18:35, 2 years 1 month ago REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates Jaguar Health, Inc. to conduct investor webcast on May 14, 2024 at 8:30 a.m. Eastern to review first-quarter 2024 financials and provide corporate updates. Company plans to file its Earnings Report on the same day Investor Webcast Form 10-Q Jaguar Health Inc. Corporate Updates First-quarter Financials
Published on 06/26/2026 at 14:05, 4 hours 9 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 4 hours 14 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 5 hours 14 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 5 hours 29 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 18:04, 10 minutes ago Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 14 minutes ago PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 14 minutes ago VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
Published on 06/26/2026 at 18:00, 14 minutes ago VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 10,2 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de produits de santé naturels
Published on 06/26/2026 at 18:00, 14 minutes ago ROCTOOL: Summary of the Roctool Annual General Meeting held on June 26, 2026